Celyad SA (ADR) (CYAD) Reaches $47.60 52-Week High; Everspin Tech (MRAM) Sellers Decreased By 1.6% Their Shorts

June 20, 2017 - By Winifred Garcia

The stock of Celyad SA (ADR) (NASDAQ:CYAD) hit a new 52-week high and has $50.93 target or 7.00% above today’s $47.60 share price. The 7 months bullish chart indicates low risk for the $459.00 million company. The 1-year high was reported on Jun, 20 by Barchart.com. If the $50.93 price target is reached, the company will be worth $32.13M more. About 1,069 shares traded. Celyad SA (ADR) (NASDAQ:CYAD) has 0.00% since June 20, 2016 and is . It has underperformed by 16.70% the S&P500.

Everspin Tech Incorporated (NASDAQ:MRAM) had a decrease of 1.6% in short interest. MRAM’s SI was 215,700 shares in June as released by FINRA. Its down 1.6% from 219,200 shares previously. With 38,100 avg volume, 6 days are for Everspin Tech Incorporated (NASDAQ:MRAM)’s short sellers to cover MRAM’s short positions. The SI to Everspin Tech Incorporated’s float is 4.37%. About 232,849 shares traded. Everspin Technologies Inc (NASDAQ:MRAM) has 0.00% since June 20, 2016 and is . It has underperformed by 16.70% the S&P500.

Everspin Technologies, Inc. is a United States well-known provider of magnetoresistive random-access memory solutions. The company has market cap of $282.57 million. The Firm is engaged in designing, manufacturing and shipping discrete and embedded MRAM and spin-torque MRAM (ST-MRAM) into markets and applications. It currently has negative earnings. The Company’s products include 8-bit/16-bit Parallel Interface MRAM, Serial Peripheral Interface (SPI), Quad SPI and Double Data Rate (DDR) 3 dynamic random-access memory (DRAM) Compatible MRAM – Spin Torque Technology.

Celyad SA, formerly Cardio3 Biosciences SA is a Belgium drug developing company. The company has market cap of $459.00 million. The Firm develops stem cell therapies for cardiovascular disease. It currently has negative earnings. The Firm focuses on developing regenerative therapies to treat illnesses where cardiac tissue is lost due to chronic or acute injury.